Article: Genentech Fires Its Chief Executive over Ethics of His Loan Request.(Originated from San Jose Mercury News, Calif.)

July 11--A questionable financial deal involving a personal loan is behind the removal of G. Kirk Raab as chief executive of Genentech Inc., the South San Francisco-based biotechnology giant.

Company directors said Monday that Raab, whose total compensation including stock options was at least $3.5 million last year, was fired Friday and replaced by long-time vice president Arthur D. Levinson, a respected researcher who has headed many of the company's key product development projects in recent years. The shake-up hit Genentech on the same day the company announced it will cancel further tests of its highly touted drug Pulmozyme, which the company projected as a new ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!